October 26, 2016
Horizon completes acquisition of Raptor
Horizon Pharma has completed the acquisition of Raptor Pharmaceutical…
Pharmaceuticals, Biotechnology and Life Sciences
Horizon Pharma has completed the acquisition of Raptor Pharmaceutical…
Horizon Pharma, with its wholly owned subsidiaries, Horizon Pharma, Inc. and Horizon Pharma USA, Inc., intends to offer $300 million aggregate principal amount of senior notes due 2024, and to borrow $375 million.
Horizon Pharma and Raptor Pharmaceutical Corp.have entered into a definitive agreement under which Horizon Pharma will acquire all of the issued…